Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Belldegrun

Showing results (101-110 of 126) with videos related to

Pageof 13
Sort By:
Cancer|October 1, 1994
In vitro modulation of the invasive and metastatic potentials of human renal cell carcinoma by interleukin-2 and/or interferon-alpha gene transferR W Hathorn, C L Tso, R Kaboo, et al.
The Journal of Urology|September 1, 1997
Treatment of metastatic renal cell carcinoma with nephrectomy, interleukin-2 and cytokine-primed or CD8(+) selected tumor infiltrating lymphocytes from primary tumorR A Figlin, W C Pierce, R Kaboo, et al.
Cancer Research|December 16, 2000
WISH-PC2: a unique xenograft model of human prostatic small cell carcinomaJ H Pinthus, T Waks, D G Schindler, et al.
Cancer Research|March 21, 1998
Highly efficient and consistent gene transfer into dendritic cells utilizing a combination of ultraviolet-irradiated adenovirus and poly(L-lysine) conjugatesP Mulders, S Pang, J Dannull, et al.
Clinical Immunology and Immunopathology|August 1, 1994
Patterns of cytokine release of unselected and CD8+ selected renal cell carcinoma tumor-infiltrating lymphocytes (TIL). Evidence for enhanced specific killing of tumor necrosis factor-secreting/IL-6 nonsecreting TIL in vitro and correlation with complete response in vivoG G Steger, W C Pierce, R Figlin, et al.
The Journal of Urology|September 24, 1999
Comparison of helical computerized tomography, positron emission tomography and monoclonal antibody scans for evaluation of lymph node metastases in patients with prostate specific antigen relapse after treatment for localized prostate cancerM A Seltzer, Z Barbaric, A Belldegrun, et al.
Annals of Internal Medicine|June 1, 1987
Effects of interleukin-2 on renal function in patients receiving immunotherapy for advanced cancerA Belldegrun, D E Webb, H A Austin, et al.
Human Gene Therapy|June 2, 2001
Interleukin 2 gene therapy for prostate cancer: phase I clinical trial and basic biologyA Belldegrun, C L Tso, A Zisman, et al.
Cancer Research|October 16, 1999
Evidence for clonal outgrowth of androgen-independent prostate cancer cells from androgen-dependent tumors through a two-step processN Craft, C Chhor, C Tran, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 25, 2000
Immunomodulatory dendritic cells generated from nonfractionated bulk peripheral blood mononuclear cell cultures induce growth of cytotoxic T cells against renal cell carcinomaA Hinkel, C L Tso, B J Gitlitz, et al.
Pageof 13

Showing results (101-110 of 126) with videos related to

Sort By:
Pageof 13
Cancer|October 1, 1994
In vitro modulation of the invasive and metastatic potentials of human renal cell carcinoma by interleukin-2 and/or interferon-alpha gene transferR W Hathorn, C L Tso, R Kaboo, et al.
The Journal of Urology|September 1, 1997
Treatment of metastatic renal cell carcinoma with nephrectomy, interleukin-2 and cytokine-primed or CD8(+) selected tumor infiltrating lymphocytes from primary tumorR A Figlin, W C Pierce, R Kaboo, et al.
Cancer Research|December 16, 2000
WISH-PC2: a unique xenograft model of human prostatic small cell carcinomaJ H Pinthus, T Waks, D G Schindler, et al.
Cancer Research|March 21, 1998
Highly efficient and consistent gene transfer into dendritic cells utilizing a combination of ultraviolet-irradiated adenovirus and poly(L-lysine) conjugatesP Mulders, S Pang, J Dannull, et al.
Clinical Immunology and Immunopathology|August 1, 1994
Patterns of cytokine release of unselected and CD8+ selected renal cell carcinoma tumor-infiltrating lymphocytes (TIL). Evidence for enhanced specific killing of tumor necrosis factor-secreting/IL-6 nonsecreting TIL in vitro and correlation with complete response in vivoG G Steger, W C Pierce, R Figlin, et al.
The Journal of Urology|September 24, 1999
Comparison of helical computerized tomography, positron emission tomography and monoclonal antibody scans for evaluation of lymph node metastases in patients with prostate specific antigen relapse after treatment for localized prostate cancerM A Seltzer, Z Barbaric, A Belldegrun, et al.
Annals of Internal Medicine|June 1, 1987
Effects of interleukin-2 on renal function in patients receiving immunotherapy for advanced cancerA Belldegrun, D E Webb, H A Austin, et al.
Human Gene Therapy|June 2, 2001
Interleukin 2 gene therapy for prostate cancer: phase I clinical trial and basic biologyA Belldegrun, C L Tso, A Zisman, et al.
Cancer Research|October 16, 1999
Evidence for clonal outgrowth of androgen-independent prostate cancer cells from androgen-dependent tumors through a two-step processN Craft, C Chhor, C Tran, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 25, 2000
Immunomodulatory dendritic cells generated from nonfractionated bulk peripheral blood mononuclear cell cultures induce growth of cytotoxic T cells against renal cell carcinomaA Hinkel, C L Tso, B J Gitlitz, et al.
Pageof 13